Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07831369 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Inova Health Care Services
31 trials monitored
See 5 trials at risk
Glioma
1,251 trials monitored
See 88 trials at risk
Glioblastoma
710 trials monitored
See 52 trials at risk
The goal of this clinical trial is to see if the combination of valproic acid, irinotecan, and simvastatin causes these tumors to stabilize or shrink, which is a sign that these combinations are effective against tumors in patients with recurrent glioblastoma and adults with recurrent IDH-mutated gliomas
Trial Details
NCT Number NCT07831369
Lead Sponsor Inova Health Care Services
Conditions
(from sponsor)		 Glioblastoma, Astrocytoma, IDH-Mutant, Grade 4
Related terms Astrocytoma, Glioblastoma
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov